Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

TXN

Texas Instruments Inc

May 14 • 04:00PM ET

308.17

+1.83 0.60 %

Technology • Semiconductors • USA • Mega • NASD

Peers: ADI MCHP MPWR ON NXPI STM SWKS QRVO QCOM INTC

| Held by: QQQ VTI SCHD VOO IVV SPY SMH XLK SOXX VGT

Index	NDX, S&P 500	P/E	52.72	EPS (ttm)	5.85	Insider Own	0.25%	Shs Outstand	910.00M	Perf Week	8.04%
Market Cap	280.46B	Forward P/E	34.74	EPS next Y	8.87	Insider Trans	-14.29%	Shs Float	907.80M	Perf Month	42.48%
Enterprise Value	289.41B	PEG	1.56	EPS next Q	1.91	Inst Own	89.75%	Short Float	1.72%	Perf Quarter	38.19%
Income	5.34B	P/S	15.21	EPS this Y	39.42%	Inst Trans	0.17%	Short Ratio	2.19	Perf Half Y	92.93%
Sales	18.44B	P/B	16.71	EPS next Y	16.76%	ROA	15.66%	Short Interest	15.59M	Perf YTD	77.63%
Book/sh	18.44	P/C	54.96	EPS next 5Y	22.21%	ROE	32.16%	52W High	309.32 -0.37%	Perf Year	64.50%
Cash/sh	5.61	P/FCF	75.37	EPS past 3/5Y	-16.65% -1.81%	ROIC	17.98%	52W Low	152.73 101.77%	Perf 3Y	90.37%
Dividend Est.	5.75 (1.87%)	EV/EBITDA	33.05	Sales past 3/5Y	-4.07% 4.10%	Gross Margin	57.32%	Volatility	2.60% 3.24%	Perf 5Y	68.15%
Dividend TTM	5.62 (1.82%)	EV/Sales	15.70	EPS Y/Y TTM	10.49%	Oper. Margin	36.02%	ATR (14)	9.38	Perf 10Y	439.51%
Dividend Ex-Date	May 05, 2026	Quick Ratio	2.94	Sales Y/Y TTM	14.89%	Profit Margin	28.94%	RSI (14)	80.18	Recom	2.37
Dividend Gr. 3/5Y	5.45% 8.13%	Current Ratio	4.46	EPS Q/Q	31.23%	SMA20	12.27%	Beta	1.31	Target Price	286.43
Payout	100.97%	Debt/Eq	0.84	Sales Q/Q	18.58%	SMA50	34.48%	Rel Volume	0.78	Prev Close	306.34
Employees	33000	LT Debt/Eq	0.77	Earnings	Apr 22 AMC	SMA200	56.30%	Avg Volume	7.13M	Price	308.17
IPO	Oct 01, 1953	Option/Short	Yes / Yes	EPS/Sales Surpr.	23.19% 6.60%	Trades		Volume	5,766,148	Change	0.60%

Date	Action	Analyst	Rating Change	Price Target Change
May-13-26	Reiterated	Cantor Fitzgerald	Neutral	$280 → $300
Apr-23-26	Upgrade	BofA Securities	Neutral → Buy	$320
Apr-23-26	Upgrade	Barclays	Underweight → Equal Weight	$250
Apr-17-26	Upgrade	Mizuho	Underperform → Neutral	$215
Apr-09-26	Upgrade	Stifel	Hold → Buy	$250
Jan-28-26	Upgrade	BofA Securities	Underperform → Neutral	$235
Jan-28-26	Reiterated	TD Cowen	Buy	$225 → $240
Jan-22-26	Upgrade	BNP Paribas Exane	Underperform → Neutral	$190
Dec-15-25	Downgrade	Goldman	Buy → Sell	$156
Oct-23-25	Reiterated	Robert W. Baird	Outperform	$220 → $195
Oct-22-25	Reiterated	TD Cowen	Buy	$210 → $200
Oct-20-25	Downgrade	Mizuho	Neutral → Underperform	$150
Oct-13-25	Downgrade	BofA Securities	Neutral → Underperform	$190
Jul-28-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$230
Jul-23-25	Reiterated	Wells Fargo	Equal Weight	$215 → $195
Jul-23-25	Reiterated	Truist	Hold	$171 → $196
Jul-23-25	Reiterated	The Benchmark Company	Buy	$200 → $220
Jul-23-25	Reiterated	TD Cowen	Buy	$245 → $230
Jul-23-25	Reiterated	Susquehanna	Positive	$250 → $240
Jul-23-25	Reiterated	Robert W. Baird	Outperform	$175 → $220

Show Previous Ratings

May-14-26 12:45PM	Trump revamps stock portfolio, adding Nvidia and other AI names (Investing.com)
May-13-26 07:48AM	Nasdaq joins Dow Jones in red at open as Trump arrives in China (Proactive)
07:48AM	Nasdaq back in positive territory but Dow still red as Trump arrives in China (Proactive)
02:17AM	FTSE 100 Live: London stocks in red, Babcock gains offset by bond worries over Starmer (Proactive)
May-11-26 02:43PM	TI CEO Haviv Ilan to speak at Bernstein investor conference (PR Newswire)
06:12PM	Loading…
May-03-26 06:12PM	AI data center demand boosts IDM growth in industrial market (DigiTimes)
May-02-26 09:00AM	Corporate America Earnings Beat Back Wall Streets Wall of Worry (Bloomberg)
Apr-30-26 04:15PM	Nasdaq leads US stocks in monthly gains following April rally (Yahoo Finance Video)
Apr-28-26 08:05PM	Exclusive: Texas Instruments VP makes the case for 800V power and GaN in AI data centers (DigiTimes)
04:59PM	NXP Semiconductors forecasts strong quarterly results, shares jump (Reuters)
11:46AM	Texas Instruments launches the TI-84 Evo Graphing Calculator -- the most advanced TI-84 ever built (PR Newswire)
10:49AM	Is Rambus Stock An AI Growth Mirage? (Trefis)
06:46AM	Techs New Normal Trade Pair: Long Chip Stock, Short Software (Bloomberg)
Apr-27-26 09:27AM	Texas Instruments Gets Wave of Analyst Upgrades After Blowout Earnings (GuruFocus.com)
Apr-24-26 03:06PM	Nvidia's stock heads for first record close in 6 months - thanks to Intel (MarketWatch)
02:29PM	Loading…
02:29PM	Investing.coms stocks of the week (Investing.com)
06:00AM	Data center boom continues to buoy Texas Instruments (Manufacturing Dive)
Apr-23-26 11:13PM	Texas Instruments eyes further price hikes amid strong data center, industrial chip demand (DigiTimes) +19.43%
10:32PM	Texas Instruments says edge AI opportunities extend beyond robots (DigiTimes)
06:45PM	Stock market today: Nasdaq futures climb as Intel soars, but Dow and S&P 500 lag amid Hormuz tensions (Yahoo Finance)
04:42PM	Texas Instruments Rises the Most Since 2000 on Rosy Forecast (Bloomberg)
03:28PM	How Stodgy Texas Instruments Became a Hot AI Chip Stock (Barrons.com)
03:25PM	Chip stocks just added $3 trillion in market value but are the most overextended in decades: Chart of the Day (Yahoo Finance)
02:41PM	Texas Instruments Q1 2026 earnings beat on AI data center demand (Quartz)
02:41PM	Texas Instruments stock is up 18% after beating earnings estimates on AI demand (Quartz)
01:24PM	On Semi and Analog Devices Stocks Head for Record Highs. Thank Texas Instruments. (Barrons.com)
01:22PM	Texas Instruments Forecast Tops Estimates, Shares Jump Over 11% (GuruFocus.com)
12:15PM	The chip sector is on a historic tear, fueled by some unsuspecting stocks (MarketWatch)
10:07AM	The Dow Falls 200 Points. It's All About Earnings. (Barrons.com)
09:58AM	Texas Instruments Stock Hits Record High After Earnings (Schaeffer's Research)
09:44AM	Loading…
09:44AM	Texas Instruments upgraded, Avis downgraded: Wall Street's top analyst calls (The Fly)
09:41AM	Stocks Pull Back From Record Highs (Barrons.com)
09:21AM	U.S. stocks seen easing after rally to record highs: Dow Jones, S&P, Nasdaq, Wall Street Futures (InvestorsHub)
05:44AM	These Stocks Are Today's Movers: Tesla, ServiceNow, IBM, Lam Research, and More (Barrons.com)
04:43AM	Texas Instruments topped Wall Street's outlook on more than just data-center demand (MarketWatch)
03:05AM	Texas Instruments Inc (TXN) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Apr-22-26 09:42PM	Texas Instruments signals a stronger recovery on industrial and AI demand (DigiTimes)
04:22PM	Texas Instruments Logs Higher First-Quarter Profit, Revenue (The Wall Street Journal)
04:19PM	Texas Instruments Reports Solid Earnings. The Stock Is Up. (Barrons.com)
04:16PM	Texas Instruments Stock Jumps On Q1 Beat-And-Raise Report (Investor's Business Daily)
04:09PM	TI projects upbeat quarterly results on strong data center chip demand (Reuters)
04:08PM	Texas Instruments: Q1 Earnings Snapshot (Associated Press)
04:01PM	TI reports first quarter 2026 financial results and shareholder returns (PR Newswire)
09:07AM	Is the chip cycle accelerating faster than expected? (Investing.com)
05:59AM	Tesla earnings in focus as more tech companies present results (MarketWatch)
03:44AM	Stock Market Today: Dow set for 300-point gain, S&P 500 and Nasdaq to rise after Trump said he would extend cease-fire with Iran; Tesla results on tap (MarketWatch)
Apr-21-26 07:00PM	Tesla, Boeing, IBM, Southwest earnings: What to Watch (Yahoo Finance Video)
11:24AM	Intel Slips as Chip Stocks Mostly Advance (GuruFocus.com)
Apr-17-26 09:36AM	Apple upgraded, Qualcomm downgraded: Wall Street's top analyst calls (The Fly)
08:08AM	NXP Semi Gets Hit With a Double Downgrade. Why Texas Instruments Stock Is a Better Bet. (Barrons.com)
Apr-16-26 04:16PM	Texas Instruments board declares second quarter 2026 quarterly dividend (PR Newswire)
Apr-12-26 05:35AM	5 big analyst AI moves: Upgrades for TXN and DDOG; Further upside seen in SNDK (Investing.com)
Apr-09-26 09:40AM	Texas Instruments upgraded, Circle downgraded: Wall Street's top analyst calls (The Fly)
08:58AM	Stifel ups Texas Instruments to Buy, sees FCF inflection as heavy capex cycle ends (Investing.com)
Apr-07-26 08:00PM	Is inTest (INTT) Stock Outpacing Its Computer and Technology Peers This Year? (Quartz)
Apr-06-26 08:36AM	Citi is bullish on these 2 chip stocks into Q1 earnings (Investing.com)
Apr-03-26 02:33PM	These little-known chip stocks could be winners as SpaceX and Amazon make big satellite pushes (MarketWatch)
Apr-01-26 11:39AM	Texas Instruments to webcast Q1 2026 earnings conference call (PR Newswire)
Mar-25-26 03:46PM	This Chip Rally Is Telling A Different Story (GuruFocus.com)
03:22PM	Texas Instruments to webcast its 2026 annual meeting of stockholders (PR Newswire)
Mar-23-26 02:18PM	Nvidia, AMD Rally As War Fears Ease (GuruFocus.com)
09:48AM	Chip Stocks Pop as Trump Hits Pause on Iran Strikes (GuruFocus.com)
09:00AM	TI unveils high-performance isolated power modules to advance power density in data centers and EVs (PR Newswire)
Mar-17-26 02:49PM	Signal: Buy the Dip on This Struggling Semiconductor Stock (Schaeffer's Research)
Mar-16-26 04:30PM	TI unveils complete 800 VDC power architecture for future generation AI data centers with NVIDIA (PR Newswire)
Mar-13-26 07:30AM	4 Top Chip Stocks to Buy Now After Earnings (Barchart)
Mar-12-26 04:35PM	Stocks Slump on Iran War and Credit Woes (Barchart)
11:10AM	Stocks Retreat Amid Rising Crude Prices and Credit Worries (Barchart)
10:08AM	Stocks Fall as Oil Prices Continue to Climb (Barchart)
09:57AM	Is ON Semiconductor Stock Outperforming the Dow? (Barchart)
Mar-10-26 11:12PM	Texas Instruments reportedly plan analog chip price hikes (DigiTimes)
02:19PM	These chip stocks could be winners in a prolonged Iran conflict (MarketWatch)
01:29PM	Texas Instruments (TXN) Signals Recovery in Factory and Automation Markets, CEO Says (Insider Monkey)
09:47AM	Company News for Mar 10, 2026 (Zacks)
09:30AM	STMicroelectronics (STM) Soars 6.9%: Is Further Upside Left in the Stock? (Zacks)
09:06AM	Micron Stock Soars 51% in Three Months: Is There More Room for Growth? (Zacks)
08:44AM	NVIDIA Soars 70% in a Year: Is There More Room for the Stock to Grow? (Zacks)
06:30AM	From Wearables To Robots: Texas Instruments Launches AI-Ready Microcontrollers (Benzinga)
04:00AM	TI expands microcontroller portfolio and software ecosystem to enable edge AI in every device (PR Newswire)
Mar-09-26 05:50PM	Texas Instruments (TXN) Outperforms Broader Market: What You Need to Know (Zacks)
02:44PM	Nvidia, Broadcom Lead Citi's Top Semiconductor Picks Amid AI Boom (GuruFocus.com)
12:33AM	2 S&P 500 Stocks with Solid Fundamentals and 1 We Turn Down (StockStory)
Mar-06-26 04:42PM	Stocks Retreat on Inflation Concerns and a Weak US Job Market (Barchart)
11:18AM	Stocks Retreat Amid Inflation Fears and Weak US Jobs (Barchart)
10:05AM	Stocks Slump on Iran War and Weak US Jobs Report (Barchart)
09:22AM	The NASDAQ Dividend Stocks Retirees Are Loading Up On Before the Next Rate Cut (24/7 Wall St.)
09:19AM	Texas Instruments to accelerate deployment of humanoid robots with Nvidia (TipRanks)
Mar-05-26 04:36PM	Stocks Finish Lower as War Rages in the Middle East (Barchart)
04:00PM	Elfun Trusts Exits Texas Instruments Inc, Impacting Portfolio by -1.57% (GuruFocus.com)
11:22AM	Stocks Fall as Crude Oil Surge Stokes Inflation Fears (Barchart)
09:00AM	TI accelerates the next generation of physical AI with NVIDIA (PR Newswire)
Mar-04-26 05:59PM	Is Texas Instruments Incorporated (TXN) A Good Stock To Buy Now? (Insider Monkey)
09:00AM	Investors Heavily Search Texas Instruments Incorporated (TXN): Here is What You Need to Know (Zacks)
Mar-03-26 04:39PM	Stocks Settle Lower on Iran War Anxiety (Barchart)
01:53PM	Nvidia, AMD, Intel, and Broadcom Lead Chip Stock Sell-off Amid Iran Crisis (GuruFocus.com)
Mar-02-26 05:50PM	Texas Instruments (TXN) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
04:37PM	Stocks Recover as Iran War Pushes Energy and Defense Stocks Higher (Barchart)
11:19AM	Markets Rebound After Initial Selloff Triggered by Middle East Tensions (Barchart)
Mar-01-26 11:39PM	3 Unpopular Stocks We're Skeptical Of (StockStory)
Feb-27-26 11:14AM	Stocks Retreat on AI Disruption Concerns and Geopolitical Risks (Barchart)

Texas Instruments Incorporated engages in the design and manufacture of semiconductors. It operates through the following segments: Analog, Embedded Processing, and Other. The Analog segment semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. The Embedded Processing segment involves handling specific tasks and can be optimized for various combinations of performance, power, and cost, depending on the application. The Other segment includes DLP products, calculators, and custom application-specific integrated circuits products. The company was founded in 1930 and is headquartered in Dallas, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
COX CARRIE SMITH	Director	May 13 '26	Option Exercise	107.21	8,838	947,492	46,464	May 14 06:49 PM
COX CARRIE SMITH	Director	May 13 '26	Sale	306.41	8,838	2,708,029	37,626	May 14 06:49 PM
RAFAEL R. LIZARDI	Officer	May 14 '26	Proposed Sale	308.10	47,734	14,706,654		May 14 03:40 PM
CARRIE S. COX	Director	May 13 '26	Proposed Sale	306.40	8,838	2,707,932		May 13 03:06 PM
Leonard Shanon J	Sr. Vice President	May 11 '26	Sale	295.22	4,963	1,465,186	24,867	May 12 05:19 PM
Shanon Leonard	Officer	May 11 '26	Proposed Sale	295.21	4,963	1,465,115		May 11 05:07 PM
Ilan Haviv	Chairman, President & CEO	May 04 '26	Option Exercise	79.26	20,000	1,585,200	224,339	May 05 04:50 PM
Ilan Haviv	Chairman, President & CEO	May 04 '26	Sale	280.32	20,000	5,606,450	204,339	May 05 04:50 PM
Knecht Julie C.	VP & Chief Accounting Officer	May 01 '26	Option Exercise	130.52	5,378	701,937	19,076	May 04 04:31 PM
Knecht Julie C.	VP & Chief Accounting Officer	May 01 '26	Sale	278.70	9,956	2,774,786	9,120	May 04 04:31 PM
Haviv Ilan	Officer	May 04 '26	Proposed Sale	280.32	20,000	5,606,450		May 04 12:50 PM
Gary Mark	Sr. Vice President	Apr 30 '26	Option Exercise	130.52	13,689	1,786,688	59,236	May 01 04:49 PM
Gary Mark	Sr. Vice President	Apr 30 '26	Sale	279.25	13,689	3,822,671	45,547	May 01 04:49 PM
Roberts Mark T.	Sr. Vice President	Apr 30 '26	Option Exercise	116.87	17,831	2,083,939	81,889	May 01 04:49 PM
Roberts Mark T.	Sr. Vice President	Apr 30 '26	Sale	280.34	28,080	7,871,934	53,809	May 01 04:49 PM
Yunus Mohammad	Sr. Vice President	Apr 29 '26	Option Exercise	161.60	51,098	8,257,600	103,954	Apr 30 04:28 PM
Yunus Mohammad	Sr. Vice President	Apr 29 '26	Sale	270.44	51,098	13,818,951	52,856	Apr 30 04:28 PM
Kane Katharine	SVP and General Counsel	Apr 27 '26	Option Exercise	166.86	6,125	1,021,992	31,337	Apr 28 04:42 PM
Kane Katharine	SVP and General Counsel	Apr 27 '26	Sale	270.41	6,125	1,656,283	25,212	Apr 28 04:42 PM
BAHAI AHMAD	Sr. Vice President	Apr 27 '26	Option Exercise	79.26	3,660	290,092	46,179	Apr 28 04:42 PM
BAHAI AHMAD	Sr. Vice President	Apr 27 '26	Sale	268.40	3,660	982,359	42,519	Apr 28 04:42 PM
Leonard Shanon J	Sr. Vice President	Apr 24 '26	Option Exercise	158.20	18,189	2,877,483	50,164	Apr 27 04:31 PM
Leonard Shanon J	Sr. Vice President	Apr 24 '26	Sale	277.95	18,189	5,055,707	31,975	Apr 27 04:31 PM
Bluedorn Todd M	Director	Apr 24 '26	Option Exercise	110.15	4,306	474,306	12,497	Apr 27 04:31 PM
Bluedorn Todd M	Director	Apr 24 '26	Sale	274.25	4,306	1,180,930	8,191	Apr 27 04:31 PM
Ron Amichai	Sr. Vice President	Apr 24 '26	Option Exercise	104.41	15,865	1,656,465	99,450	Apr 27 04:31 PM
Ron Amichai	Sr. Vice President	Apr 24 '26	Sale	272.43	18,365	5,003,214	81,085	Apr 27 04:31 PM
BLINN MARK A	Director	Apr 24 '26	Sale	277.51	15,000	4,162,689	0	Apr 27 04:31 PM
Lizardi Rafael R	Sr. Vice President & CFO	Apr 24 '26	Option Exercise	169.23	40,541	6,860,753	126,026	Apr 27 04:31 PM
Lizardi Rafael R	Sr. Vice President & CFO	Apr 24 '26	Sale	274.23	40,541	11,117,556	85,485	Apr 27 04:31 PM
PATSLEY PAMELA H	Director	Apr 24 '26	Option Exercise	110.15	4,306	474,306	38,793	Apr 27 04:31 PM
PATSLEY PAMELA H	Director	Apr 24 '26	Sale	276.11	4,306	1,188,918	34,487	Apr 27 04:31 PM
Witzsche Christine	Sr. Vice President	Apr 24 '26	Option Exercise	107.38	3,625	389,261	29,242	Apr 27 04:31 PM
Witzsche Christine	Sr. Vice President	Apr 24 '26	Sale	275.52	3,625	998,771	25,617	Apr 27 04:31 PM
Katharine Kane	Officer	Apr 27 '26	Proposed Sale	270.41	6,125	1,656,283		Apr 27 01:51 PM
Pamela Patsley	Director	Apr 24 '26	Proposed Sale	276.11	4,306	1,188,919		Apr 24 04:57 PM
Rafael Lizardi	Officer	Apr 24 '26	Proposed Sale	274.23	40,541	11,117,557		Apr 24 03:47 PM
Shanon Leonard	Officer	Apr 24 '26	Proposed Sale	277.95	18,189	5,055,706		Apr 24 03:47 PM
Todd Bluedorn	Director	Apr 24 '26	Proposed Sale	274.25	4,306	1,180,930		Apr 24 03:47 PM
Christine Witzsche	Officer	Apr 24 '26	Proposed Sale	275.52	3,625	998,771		Apr 24 03:47 PM
BLINN MARK A	Director	Apr 24 '26	Proposed Sale	276.54	15,000	4,148,066		Apr 24 12:27 PM
Kozanian Hagop H	Sr. Vice President	Feb 17 '26	Sale	225.95	6,843	1,546,168	75,425	Feb 18 04:58 PM
BAHAI AHMAD	Sr. Vice President	Feb 11 '26	Option Exercise	79.26	6,500	515,190	48,988	Feb 12 04:26 PM
BAHAI AHMAD	Sr. Vice President	Feb 11 '26	Sale	230.79	6,500	1,500,117	42,488	Feb 12 04:26 PM
Gary Mark	Sr. Vice President	Feb 11 '26	Option Exercise	110.15	12,921	1,423,248	58,468	Feb 12 04:26 PM
Gary Mark	Sr. Vice President	Feb 11 '26	Sale	230.10	12,921	2,973,107	45,547	Feb 12 04:26 PM
Gary Mark	Sr. Vice President	Feb 10 '26	Sale	220.83	10,248	2,263,098	45,547	Feb 12 04:26 PM
Lizardi Rafael R	Sr. Vice President & CFO	Feb 10 '26	Option Exercise	130.52	64,532	8,422,717	157,082	Feb 12 04:25 PM
Lizardi Rafael R	Sr. Vice President & CFO	Feb 10 '26	Sale	220.74	64,532	14,244,539	92,550	Feb 12 04:25 PM
Lizardi Rafael R	Sr. Vice President & CFO	Feb 11 '26	Sale	230.78	7,096	1,637,611	85,454	Feb 12 04:25 PM
Rafael Lizardi	Officer	Feb 11 '26	Proposed Sale	230.78	7,096	1,637,611		Feb 11 03:05 PM
Rafael Lizardi	Officer	Feb 10 '26	Proposed Sale	220.74	64,532	14,244,537		Feb 10 04:57 PM
Roberts Mark T.	Sr. Vice President	Feb 09 '26	Sale	221.16	4,461	986,604	64,058	Feb 10 04:28 PM
BLINN MARK A	Director	Feb 05 '26	Option Exercise	175.48	2,572	451,344	14,814	Feb 06 04:22 PM
BLINN MARK A	Director	Feb 05 '26	Sale	221.58	3,144	696,647	11,670	Feb 06 04:22 PM
BAHAI AHMAD	Sr. Vice President	Feb 05 '26	Option Exercise	79.26	3,000	237,780	45,488	Feb 06 04:22 PM
BAHAI AHMAD	Sr. Vice President	Feb 05 '26	Sale	223.46	3,000	670,387	42,488	Feb 06 04:22 PM
Richard K. Templeton	Former Chairman of the Board	Feb 05 '26	Proposed Sale	223.98	333,615	74,723,088		Feb 05 04:41 PM
Mark Blinn	Director	Feb 05 '26	Proposed Sale	221.58	3,144	696,647		Feb 05 02:07 PM
KIRK RONALD	Director	Nov 24 '25	Option Exercise	52.93	9,990	528,771	24,927	Nov 25 05:44 PM
KIRK RONALD	Director	Nov 24 '25	Sale	162.33	9,990	1,621,688	14,937	Nov 25 05:44 PM
RONALD KIRK	Officer	Nov 24 '25	Proposed Sale	162.33	9,990	1,621,688		Nov 24 04:01 PM
Witzsche Christine	Sr. Vice President	Nov 13 '25	Option Exercise	52.93	1,000	52,930	21,821	Nov 14 04:03 PM
Witzsche Christine	Sr. Vice President	Nov 13 '25	Sale	164.31	1,000	164,306	20,821	Nov 14 04:03 PM
CHRISTINE WITZSCHE	Officer	Nov 13 '25	Proposed Sale	164.31	1,000	164,306		Nov 13 03:19 PM
BLINN MARK A	Director	Jul 21 '25	Sale	216.75	0	72	3,046	Aug 27 01:35 PM
BAHAI AHMAD	Sr. Vice President	Aug 25 '25	Option Exercise	79.26	1,500	118,890	40,383	Aug 27 12:25 PM
BAHAI AHMAD	Sr. Vice President	Aug 25 '25	Sale	205.35	1,500	308,030	38,883	Aug 27 12:25 PM

Open in Screener

OGN

Organon & Co

May 14 • 04:00PM ET

13.36

+0.02 0.15 %

Healthcare • Drug Manufacturers - General • USA • Mid • NYSE

Peers: BHC VTRS TEVA PRGO AMPH

| Held by: IJR VTI VB FXH IJS SPSM VBR SLYV VXF SCHA

Index	-	P/E	14.23	EPS (ttm)	0.94	Insider Own	0.53%	Shs Outstand	262.65M	Perf Week	0.30%
Market Cap	3.51B	Forward P/E	3.65	EPS next Y	3.66	Insider Trans	1.94%	Shs Float	261.22M	Perf Month	45.06%
Enterprise Value	10.96B	PEG	2.21	EPS next Q	0.92	Inst Own	75.31%	Short Float	7.46%	Perf Quarter	89.24%
Income	246.00M	P/S	0.57	EPS this Y	-5.95%	Inst Trans	-0.39%	Short Ratio	2.18	Perf Half Y	77.66%
Sales	6.16B	P/B	3.89	EPS next Y	6.37%	ROA	1.88%	Short Interest	19.49M	Perf YTD	86.33%
Book/sh	3.44	P/C	3.14	EPS next 5Y	1.65%	ROE	34.05%	52W High	13.44 -0.60%	Perf Year	66.17%
Cash/sh	4.25	P/FCF	5.14	EPS past 3/5Y	-41.56% -39.04%	ROIC	2.60%	52W Low	5.69 134.80%	Perf 3Y	-35.98%
Dividend Est.	0.06 (0.48%)	EV/EBITDA	7.08	Sales past 3/5Y	0.23% -1.00%	Gross Margin	53.22%	Volatility	0.47% 3.11%	Perf 5Y	-59.82%
Dividend TTM	0.08 (0.60%)	EV/Sales	1.78	EPS Y/Y TTM	-67.52%	Oper. Margin	19.34%	ATR (14)	0.37	Perf 10Y	-
Dividend Ex-Date	May 11, 2026	Quick Ratio	1.42	Sales Y/Y TTM	-2.08%	Profit Margin	3.99%	RSI (14)	77.56	Recom	3.50
Dividend Gr. 3/5Y	-32.79% -	Current Ratio	1.97	EPS Q/Q	66.64%	SMA20	9.85%	Beta	1.54	Target Price	11.25
Payout	47.41%	Debt/Eq	9.49	Sales Q/Q	-3.50%	SMA50	50.52%	Rel Volume	0.43	Prev Close	13.34
Employees	10000	LT Debt/Eq	9.47	Earnings	Apr 30 BMO	SMA200	55.31%	Avg Volume	8.95M	Price	13.36
IPO	May 14, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-14.32% -1.85%	Trades		Volume	3,938,786	Change	0.15%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-28-26	Upgrade	Piper Sandler	Underweight → Neutral	$14
Dec-09-25	Initiated	Barclays	Underweight	$7.50
Oct-27-25	Downgrade	Piper Sandler	Overweight → Underweight	$5
May-02-25	Downgrade	Evercore ISI	Outperform → In-line
Sep-06-24	Downgrade	JP Morgan	Neutral → Underweight	$18 → $20
Nov-03-23	Downgrade	Goldman	Buy → Neutral	$33 → $16
Sep-21-23	Initiated	Barclays	Overweight	$28
Mar-16-23	Initiated	Raymond James	Outperform	$33
Oct-14-22	Downgrade	BofA Securities	Neutral → Underperform	$27 → $25
Sep-06-22	Upgrade	Piper Sandler	Neutral → Overweight	$37 → $34
Aug-05-22	Downgrade	BofA Securities	Buy → Neutral	$40 → $37
Apr-27-22	Initiated	Goldman	Buy	$40
Apr-06-22	Resumed	Morgan Stanley	Equal-Weight	$35
Oct-07-21	Initiated	Piper Sandler	Neutral	$35
Sep-01-21	Initiated	BofA Securities	Buy	$43
Jul-22-21	Initiated	Citigroup	Buy	$35
Jun-15-21	Initiated	JP Morgan	Neutral	$38
Jun-11-21	Initiated	Morgan Stanley	Equal-Weight	$33
Jun-10-21	Initiated	Evercore ISI	Outperform

Show Previous Ratings

May-14-26 05:25PM	Are XOMA, OGN, VRE Obtaining Fair Deals for their Shareholders? (PR Newswire)
May-13-26 05:00AM	Indias pharma industry is going global. But can it catch up to China? (Pharma Voice)
May-07-26 04:52AM	Lilly, Gilead lead pharmas M&A boom (Pharma Voice)
May-04-26 02:55PM	Are OGN, TBRG, CYCN Obtaining Fair Deals for their Shareholders? (PR Newswire)
Apr-30-26 07:45AM	Organon: Q1 Earnings Snapshot (Associated Press)
07:30AM	Loading…
07:30AM	Organon Reports Results for the First Quarter Ended March 31, 2026 (Business Wire)
Apr-29-26 10:00AM	European Commission (EC) Approves Henlius and Organon's POHERDY (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe (PR Newswire)
07:30AM	Organon Cancels First Quarter Earnings Call (Business Wire)
Apr-28-26 10:19AM	Micron initiated, Rambus downgraded: Wall Street's top analyst calls (The Fly)
04:00AM	As biosimilars gain US traction, patent thickets are under more scrutiny (Pharma Voice)
Apr-27-26 01:06PM	Shell acquiring Arc for $13.6B, China blocks Meta's bid for Manus AI (Yahoo Finance Video) +16.87%
01:01PM	Sun Pharma Joins the Big Table With Organon Acquisition (Moby)
11:24AM	Are OGN, RMAX, XOMA, REAX Obtaining Fair Deals for their Shareholders? (PR Newswire)
11:07AM	Budget airlines propose relief plan to Trump, Sun Pharma's $12B deal for Organon (Yahoo Finance Video)
09:37AM	Stocks to Watch Monday: Frontier, Domino's Pizza, Qualcomm (The Wall Street Journal)
08:09AM	Loading…
08:09AM	Sun Pharma to acquire Organon in $11.75 billion deal (Quartz)
08:09AM	Sun Pharmaceutical is buying Organon in an $11.75 billion all-cash deal (Quartz)
06:16AM	Indias Sun Pharma Plots $12 Billion Organon Buyout For Global Reach (Bloomberg)
06:15AM	These Stocks Are Today's Movers: Qualcomm, Apple, Intel, Adidas, and More (Barrons.com)
06:11AM	Organon Jumps 15% as Sun Pharma Agrees $11.8bn Buyout (InvestorsHub)
05:57AM	Premarket movers: Organon, Qualcomm, Apple (MarketWatch)
05:50AM	Sun Pharma to acquire Organon for $11.75bn (Pharmaceutical Business Review)
05:22AM	Organon Stock Jumps After Sun Seals Takeover. Why Pharma M&A Is a Hot Play. (Barrons.com)
01:19AM	Sun Pharma to buy US drugmaker Organon for $11.75 billion in India's largest pharma deal (Reuters)
Apr-26-26 09:53PM	India's Sun Pharma to buy US-listed Organon in $11.75 billion deal (Reuters)
09:16PM	Sun Pharmaceutical to Acquire Organon Valued at $11.75 Billion (The Wall Street Journal)
07:51PM	Sun Pharma signs Definitive Agreement to Acquire Organon (Business Wire)
Apr-24-26 01:09PM	Organon Stock Surges on Sweetened $13 Billion Takeover Offer From Sun Pharma (Barrons.com) +30.93%
Apr-16-26 07:30AM	Organon To Report First Quarter 2026 Results and Host Conference Call on May 7, 2026 (Business Wire)
Apr-15-26 07:30AM	Organons VTAMA (tapinarof) cream, 1%, Granted Strong Recommendation in the 2026 American Academy of Dermatology Guidelines for Pediatric Atopic Dermatitis (Business Wire) +5.86%
02:43PM	Loading…
Apr-10-26 02:43PM	Organon Jumps 25% As Report Cites $12 Billion Sun Pharma Offer (GuruFocus.com) +27.79%
10:01AM	This Women's Health Company Is Drawing Takeover Interest. The Stock Is Soaring. (Barrons.com)
09:25AM	This Womens Healthcare Stock Is Up 15% on Reports of a Takeover In the Works (Investopedia)
08:46AM	Organon climbs on report of takeover bid and more stocks on the move (MarketWatch)
Mar-27-26 08:00AM	Organon Debuts New Analysis of VTAMA (tapinarof) cream, 1%, Phase 3 Pooled Data Demonstrating Early and Consistent Skin Clearance and Itch Improvement in Atopic Dermatitis Patients Down to 2 Years of Age (Business Wire)
Mar-24-26 07:01AM	Organon: A High Cash Yield Hidden Behind Patent Fatigue (GuruFocus.com)
Mar-02-26 12:59PM	OGN's VTAMA Cream Shows Sleep Benefits in Pediatric Atopic Dermatitis (Zacks)
Feb-27-26 08:00AM	New Analysis of Organons VTAMA (tapinarof) cream, 1%, Phase 3 Data Showed Early and Consistent Improvement in Patient-Reported Sleep Subdomains in Pediatric Patients Down to 2 Years of Age with Atopic Dermatitis (Business Wire)
Feb-23-26 04:37PM	Organon & Co. (OGN) Posts FY Adjusted EPS of $3.66, EBITDA Margin at 30.7% (Insider Monkey)
07:30AM	Organon Enters into Agreement to License MIUDELLA, Sebela Pharmaceuticals' Hormone-Free Intrauterine Device (Business Wire)
Feb-19-26 12:39AM	5 Revealing Analyst Questions From Organon's Q4 Earnings Call (StockStory)
Feb-13-26 01:09AM	Organon & Co. Q4 Earnings Call Highlights (MarketBeat)
12:34AM	OGN Q4 Deep Dive: Margin Compression and U.S. Headwinds Shape 2026 Outlook (StockStory)
Feb-12-26 04:32PM	Organon & Co. Q4 2025 Earnings Call Summary (Moby) -8.19%
04:04PM	Organon & Co (OGN) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
10:30AM	Organon (OGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:50AM	Organon (OGN) Misses Q4 Earnings and Revenue Estimates (Zacks)
08:01AM	Organon (NYSE:OGN) Reports Q4 CY2025 In Line With Expectations (StockStory)
07:51AM	Organon: Q4 Earnings Snapshot (Associated Press Finance)
07:30AM	Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025 (Business Wire)
Feb-10-26 10:05PM	Organon Earnings: What To Look For From OGN (StockStory)
Feb-02-26 05:50PM	Organon (OGN) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Jan-29-26 01:28PM	Organon Completes Divesture of JADA System to Laborie Medical (Zacks)
Jan-28-26 12:45PM	Organon Completes Divestiture of JADA System to Laborie (Business Wire)
Jan-27-26 05:50PM	Organon (OGN) Stock Sinks As Market Gains: What You Should Know (Zacks)
Jan-22-26 06:46AM	Sun Pharma Eyes Organon In What Could Be India Pharma's Biggest Cross-Border Deal: Report (Benzinga)
Jan-21-26 06:00PM	Organon (OGN) Outperforms Broader Market: What You Need to Know (Zacks)
Jan-20-26 03:10PM	Why Are Organon (OGN) Shares Soaring Today (StockStory) +7.99%
11:04AM	Organon Secures FDA Approval Extending NEXPLANON Use to Five Years (Zacks)
10:31AM	Sun Pharma Eyes Organon In What Could Be India Pharma's Biggest Cross-Border Deal: Report (Benzinga)
Jan-16-26 09:12PM	Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON (etonogestrel implant) 68 mg Radiopaque (Business Wire)
08:53AM	JPM26: AbbVie highlights growth drivers as it moves away from Humira dependency (Pharmaceutical Technology)
Jan-15-26 05:50PM	Organon (OGN) Exceeds Market Returns: Some Facts to Consider (Zacks)
Jan-14-26 06:00PM	Organon (OGN) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
Jan-08-26 01:30AM	Organon Enters into a Commercialization Agreement for Daiichi Sankyos Nilemdo in France, Denmark, Iceland, Sweden, Finland and Norway (Business Wire)
Jan-05-26 06:00PM	Organon (OGN) Surpasses Market Returns: Some Facts Worth Knowing (Zacks) +8.47%
Dec-24-25 09:00AM	Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock (Zacks)
Dec-22-25 05:50PM	Organon (OGN) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
Dec-12-25 09:00AM	Is Trending Stock Organon & Co. (OGN) a Buy Now? (Zacks)
Dec-09-25 04:01PM	Why Organon (OGN) Shares Are Trading Lower Today (StockStory)
Dec-01-25 09:00AM	Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Nov-30-25 11:03PM	Organon (OGN): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
Nov-25-25 10:32PM	Q3 Rundown: Organon (NYSE:OGN) Vs Other Branded Pharmaceuticals Stocks (StockStory) +6.37%
07:30AM	Organon To Present at the Piper Sandler 37th Annual Healthcare Conference (Business Wire)
Nov-18-25 09:00AM	Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Nov-17-25 01:14PM	Henlius and Organon score first US Perjeta biosimilar approval (Pharmaceutical Technology)
05:30AM	Henlius and Organon Announce US FDA Approval of POHERDY (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US (Business Wire)
12:34AM	The 5 Most Interesting Analyst Questions From Organon's Q3 Earnings Call (StockStory)
Nov-11-25 12:50PM	Organon & Co. (OGN) Climbs 13.7% Ahead of Dividends (Insider Monkey)
12:26PM	Organon (OGN) Stock Trades Down, Here Is Why (StockStory)
12:31AM	OGN Q3 2025 Deep Dive: Leadership Changes, Portfolio Shifts, and Guidance Recalibration (StockStory)
Nov-10-25 04:01PM	Organon & Co (OGN) Q3 2025 Earnings Call Highlights: Strong Biosimilars Performance Amidst ... (GuruFocus.com) +13.72%
01:30PM	Organon (OGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
10:06AM	Laborie inks $465M deal to buy post-childbirth device from Organon (MedTech Dive)
08:45AM	Organon (OGN) Q3 Earnings and Revenues Beat Estimates (Zacks)
08:01AM	Organon (NYSE:OGN) Posts Better-Than-Expected Sales In Q3 (StockStory)
07:45AM	Organon: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Organon Reports Results for the Third Quarter Ended September 30, 2025 (Business Wire)
Nov-08-25 10:02PM	Organon (OGN) Reports Earnings Tomorrow: What To Expect (StockStory)
Nov-07-25 12:50PM	Organon divests JADA system to Laborie in $465m deal (Medical Device Network)
07:30AM	Organon Announces Agreement to Divest its JADA System for Up to $465 Million to Laborie (Business Wire)
Nov-06-25 07:30AM	Organon To Report Third Quarter 2025 Results and Host Conference Call on November 10, 2025 (Business Wire) +5.17%
Oct-30-25 04:56AM	Jim Cramer's "Worst Stock Ever" Might Be Organon (OGN) (Insider Monkey)
Oct-28-25 03:21PM	Why Organon (OGN) Stock Is Down Today (StockStory) -5.67%
Oct-27-25 01:30PM	Organon CEO stands down amid contraceptive sales malpractice probe (Medical Device Network) -22.93%
01:26PM	This Drugmaker Made 'Improper' Sales to Meet Guidance. The Stock Plummets 25%. (Barrons.com)
Oct-23-25 05:50PM	Organon (OGN) Laps the Stock Market: Here's Why (Zacks)
10:00AM	Organon (OGN) Earnings Expected to Grow: Should You Buy? (Zacks)
Oct-22-25 08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Oct-21-25 09:00AM	Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women's health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Holzbaur Lynette	Affiliate	May 06 '26	Proposed Sale	13.35	26,448	353,080		May 08 08:31 PM
Holzbaur Lynette	SVP and Corporate Controller	May 06 '26	Buy	13.35	26,448	353,080	52,851	May 07 10:02 AM
Drinane Juliana Papa	Interim Head of Mfg & Supply	Mar 31 '26	Option Exercise	0.00	16,451	0	36,687	Apr 02 04:26 PM
Arjona Ferreira Juan Camilo	Head of R&D & CMO	Mar 31 '26	Option Exercise	0.00	13,431	0	34,867	Apr 02 04:18 PM
Karp Daniel	Executive VP, Corp. Dev.	Mar 31 '26	Option Exercise	0.00	18,053	0	71,653	Apr 02 04:17 PM
Stahler Rachel A	Chief Information Officer	Mar 31 '26	Option Exercise	0.00	18,867	0	120,322	Apr 02 04:14 PM
WALSH MATTHEW M	Chief Financial Officer	Mar 31 '26	Option Exercise	0.00	33,593	0	220,126	Apr 02 04:13 PM
Falcione Aaron	Chief Human Resources Officer	Mar 31 '26	Option Exercise	0.00	17,925	0	105,265	Apr 02 04:11 PM
Weaver Kirke	Gen. Counsel & Corp. Secy.	Mar 31 '26	Option Exercise	0.00	18,513	0	96,147	Apr 02 04:09 PM
Nisita Vittorio	Head of Global Business Svcs	Mar 31 '26	Option Exercise	0.00	13,000	0	73,494	Apr 02 04:07 PM
Holzbaur Lynette	SVP and Corporate Controller	Mar 31 '26	Option Exercise	0.00	10,967	0	28,316	Apr 02 04:06 PM
Morrissey Joseph T. Jr.	Interim CEO	Mar 31 '26	Option Exercise	0.00	24,584	0	127,907	Apr 02 04:02 PM
Stahler Rachel A	Chief Information Officer	Mar 29 '26	Option Exercise	0.00	8,200	0	106,510	Mar 31 04:16 PM
Holzbaur Lynette	SVP and Corporate Controller	Mar 29 '26	Option Exercise	0.00	5,319	0	19,995	Mar 31 04:15 PM
Karp Daniel	Executive VP, Corp. Dev.	Mar 29 '26	Option Exercise	0.00	14,184	0	60,853	Mar 31 04:14 PM
Weaver Kirke	Gen. Counsel & Corp. Secy.	Mar 29 '26	Option Exercise	0.00	7,757	0	81,611	Mar 31 04:12 PM
Nisita Vittorio	Head of Global Business Svcs	Mar 29 '26	Option Exercise	0.00	5,762	0	64,046	Mar 31 04:11 PM
Drinane Juliana Papa	Interim Head of Mfg & Supply	Mar 29 '26	Option Exercise	0.00	7,979	0	25,154	Mar 31 04:10 PM
Arjona Ferreira Juan Camilo	Head of R&D & CMO	Mar 29 '26	Option Exercise	0.00	8,865	0	23,909	Mar 31 04:09 PM
Falcione Aaron	Chief Human Resources Officer	Mar 29 '26	Option Exercise	0.00	8,422	0	92,531	Mar 31 04:08 PM
WALSH MATTHEW M	Chief Financial Officer	Mar 29 '26	Option Exercise	0.00	15,071	0	195,822	Mar 31 04:06 PM
Morrissey Joseph T. Jr.	Interim CEO	Mar 29 '26	Option Exercise	0.00	9,752	0	108,323	Mar 31 04:05 PM
COX CARRIE SMITH	Executive Chair	Nov 12 '25	Buy	7.67	65,400	501,755	77,869	Nov 13 04:05 PM
Drinane Juliana Papa	Interim Head of Mfg & Supply	Nov 07 '25	Option Exercise	0.00	3,626	0	18,417	Nov 12 05:48 PM
Arjona Ferreira Juan Camilo	Head of R&D & CMO	Nov 07 '25	Option Exercise	0.00	6,446	0	31,223	Nov 10 04:14 PM
Holzbaur Lynette	SVP and Corporate Controller	Nov 07 '25	Option Exercise	0.00	2,417	0	15,365	Nov 10 04:04 PM
Holzbaur Lynette	SVP and Corporate Controller	Nov 05 '25	Option Exercise	0.00	3,037	0	13,814	Nov 06 04:11 PM
Arjona Ferreira Juan Camilo	Head of R&D & CMO	Aug 11 '25	Option Exercise	0.00	11,519	0	28,899	Aug 12 04:05 PM

TXN

Texas Instruments Inc

OGN

Organon & Co

Upgrade your Finviz experience